CAPTRUST Financial Advisors
BCYC

CAPTRUST Financial Advisors’s Bicycle Therapeutics BCYC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-354
Closed -$6K – 2263
2022
Q2 		$6K Hold
354
– – ﹤0.01% 3982
2022
Q1 		$16K Sell
354
-1,906
-84% -$89K ﹤0.01% 3524
2021
Q4 		$138K Hold
2,260
– – ﹤0.01% 1920
2021
Q3 		$94K Sell
2,260
-1,000
-31% -$35K ﹤0.01% 2126
2021
Q2 		$99K Hold
3,260
– – ﹤0.01% 2036
2021
Q1 		$97K Buy
3,260
+260
+9% +$6.71K ﹤0.01% 1972
2020
Q4 		$54K Buy
+3,000
New +$57.9K ﹤0.01% 1790

Other funds holding BCYC

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

CAPTRUST Financial Advisors's BCYC Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Bicycle Therapeutics (BCYC) in Q3 2022, closing a stake of 354 shares — an estimated $6K sold.

CAPTRUST Financial Advisors first reported a position in BCYC in Q4 2020 and held it in 7 quarters. The position peaked at $138K in Q4 2021. 79 funds tracked by Wall St. Rank hold BCYC as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Bicycle Therapeutics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 354 Bicycle Therapeutics shares in Q3 2022, an estimated $6K.
  • CAPTRUST Financial Advisors first reported a position in Bicycle Therapeutics in Q4 2020 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Bicycle Therapeutics position peaked at $138K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.